Xue et al. Stem Cell Res Ther (2021) 12:493 https://doi.org/10.1186/s13287-021-02566-5
CORRECTION
Correction to: CD90 low glioma-associated mesenchymal stromal/stem cells promote temozolomide resistance by activating FOXS1-mediated epithelial-mesenchymal transition in glioma cells
Bing‑zhou Xue
1†, Wei Xiang
1†, Qing Zhang
1,2, Hao‑fei Wang
1, Yu‑jie Zhou
1, Han Tian
1, Ahmed Abdelmaksou
1,3, Jian Xue
4, Min‑xuan Sun
5, Dong‑ye Yi
1, Nan‑xiang Xiong
1, Xiao‑bing Jiang
1, Hong‑yang Zhao
1and Peng Fu
1*© The Author(s) 2021. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecom‑
mons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Correction to: Stem Cell Research & Therapy (2021) 12:394 https:// doi. org/ 10. 1186/ s13287- 021- 02458- 8
The original article [1] contained an error in Fig. 3B which was given wrong marking figures of NC.U87(0h) and KD.U87(0h).
The original figures and data of Fig. 3 were checked by the authors and the editors of this article, no more figure or data was changed.
The corrected Fig. 3 is presented ahead.
Author details
1 Department of Neurosurgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China. 2 Brain Tumor Research Center, Beijing Neurosurgical Institute, Capital Medical Univer‑
sity, Beijing 100050, China. 3 Department of Neurosurgery, Faculty of Medicine, Helwan University, Cairo 11435, Egypt. 4 Henan Vocational University of Science and Technology, Zhoukou 466000, China. 5 Jiangsu Key Lab of Medical Optics, Suzhou Institute of Biomedical Engineering and Technology, Chinese Acad‑
emy of Sciences, Suzhou 215163, China.
Open Access
The original article can be found online at https:// doi. org/ 10. 1186/ s13287‑
021‑ 02458‑8.
*Correspondence: pfu@hust.edu.cn
†Bing‑zhou Xue and Wei Xiang contributed equally to this work
1 Department of Neurosurgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China Full list of author information is available at the end of the article
Page 2 of 2 Xue et al. Stem Cell Res Ther (2021) 12:493
•fast, convenient online submission
•
thorough peer review by experienced researchers in your field
• rapid publication on acceptance
• support for research data, including large and complex data types
•
gold Open Access which fosters wider collaboration and increased citations maximum visibility for your research: over 100M website views per year
•
At BMC, research is always in progress.
Learn more biomedcentral.com/submissions Ready to submit your research
Ready to submit your research ? Choose BMC and benefit from: ? Choose BMC and benefit from:
Reference
1. Bing‑zhou X, et al. CD90low glioma‑associated mesenchymal stromal/
stem cells promote temozolomide resistance by activating FOXS1‑
mediated epithelial‑mesenchymal transition in glioma cells. Stem Cell Res Ther. 2021;12:394. https:// doi. org/ 10. 1186/ s13287‑ 021‑ 02458‑8.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in pub‑
lished maps and institutional affiliations.
Fig. 3 FOXS1 overexpression induces TMZ resistance in glioma cells. The proliferation (A), wound‑healing (B) and apoptosis assay (C) of glioma cells with different FOXS1 expression under 200 μM TMZ treatment. control, normal control; NC, negative control; KD, knockdown; OE, overexpression (n ≥ 3, *P < 0.05, ***P < 0.001)
